Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
The Galleri blood test is an advanced multi-cancer early detection (MCED) test designed to identify over 50 types of cancer through a single blood draw. Developed using cutting-edge genomic and methylation technology, the test detects cancer-specific signals by analyzing cell-free DNA (cfDNA) shed by tumors into the bloodstream. It not only identifies the presence of cancer but also provides information about the likely tissue of origin, aiding in targeted follow-up diagnostics. While not a replacement for routine cancer screenings, the Galleri test offers a promising tool for detecting cancers that often go unnoticed until later stages, potentially improving early detection and survival outcomes.
A recent phase 2 clinical trial conducted by the University of Iowa has revealed that adding high-dose intravenous (IV) vitamin C to standard chemotherapy significantly improves outcomes for patients with stage 4 metastatic pancreatic cancer. The study found that patients receiving the combined treatment had an average overall survival of 16 months, compared to 8 months for those receiving chemotherapy alone. Additionally, progression-free survival increased from 4 to 6 months. Patients undergoing the combined therapy also reported fewer side effects and better tolerance to treatment. These promising results suggest that high-dose IV vitamin C could enhance the effectiveness of chemotherapy in treating this aggressive cancer. https://medicine.uiowa.edu/content/high-dose-iv-vitamin-c-plus-chemotherapy-doubles-survival-advanced-pancreatic-cancer
Dr. Brian Lawenda introduces Signatera testing as a personalized tool for monitoring cancer recurrence or progression by analyzing the tumor’s unique DNA fingerprint in the bloodstream. He explains its role alongside imaging, physical exams, and other tumor marker tests, emphasizing its value in high-risk situations. When the test trends upward, it signals potential disease progression or recurrence, prompting closer monitoring and possibly earlier intervention.
Are you or someone you know struggling with the pain and stiffness of osteoarthritis? In this video, Dr. Brian Lawenda introduces an innovative, non-invasive treatment that uses targeted radiation to calm inflammation, reduce pain, and improve mobility. This treatment is: ✅ Safe and painless ✅ Quick – just two sessions per week for three weeks ✅ Effective – up to 70% of patients experience long-lasting relief ✅ A potential way to delay or avoid joint replacement surgery Whether it’s your knees, hips, hands, or feet causing discomfort, this therapy could be a game-changer. Learn how this widely used European method is helping patients regain their mobility and quality of life. 🔗 Watch now to discover if this treatment is right for you!
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.